49 results about "Vaginal blood loss" patented technology

The invention belongs to the technical field of traditional Chinese medicines, and discloses a Shenghua decoction added with Radix Codonopsis for preventing intrauterine adhesion after artificial abortion and a preparation method of the Shenghua decoction. The Shenghua decoction added with Radix Codonopsis for preventing intrauterine adhesion after artificial abortion consists of Radix Codonopsis,Radix Astragali, Semen Persicae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Zingiberis Preparatum, Herba Leonuri, Pollen Tyjphae (parched), Fructus Aurantii (parched), Herba Taraxaci, Radix Cyathulae and Radix Glycyrrhizae Preparata. Medicines are added or reduced on the basis of the formula. By the Shenghua decoction added with Radix Codonopsis for preventing intrauterine adhesion after artificial abortion, the time of vaginal bleeding after induced abortion can be shortened; first menstrual resurgence after induced abortion is improved; postoperative periodic abdominal pain is improved; and uterine cavity adhesion rate is reduced. The medicine taking types of patients are reduced, and the cost of the patients is saved; the medicine taking period and the visiting times of thepatients are reduced, and the cost of the patients is reduced; the postoperative uterine cavity adhesion rate is reduced, the possibility of secondary operation is reduced, and the hospitalization frequency of the patients is reduced, so that the expenditure of the patients and national medical insurance can be reduced; The formula has a remarkable curative effect, the influence of traditional Chinese medicines is expanded, and the propaganda cost of traditional Chinese medicine culture is indirectly saved. The new medicine provided by the invention can effectively reduce adverse reaction after induced abortion; and the influence of the traditional Chinese medicine is expanded, and Chinese cultural legacy is promoted.

The invention belongs to the technical field of medicine, and relates to a traditional Chinese medicine for treating vaginal bleeding after medical abortion. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 9-15 parts of Panax ginseng, 20-28 parts of Angelica sinensis, 6-12 parts of Ligusticum chuanxiong, 3-9 parts of Semen Persicae, 2-4 parts of dried ginger, 2-4 parts of processed radix glycyrrhizae, 20-28 parts of Agrimonia pilosa, 20-28 parts of lotus rhizome node, 9-15 parts of Hibiscus rosa-sinensis flower, 7-13 parts of Radix Rubiac Cordifoliae, 6-12 parts of Fineleaf Schizonepeta Herb, 7-13 parts of Paeonia suffruticosa bark, 7-13 parts of ass-hide glue, 2-4 parts of Squama manitis, 3-9 parts of parched Vaccaria segetalis, 3-9 parts of Radix Arnebiae, 3-9 parts of Scrophularia ningpoensis, and 2-4 parts of Panax notoginseng powder. According to clinical trial results, the cure rate is 82.0% and the total effective rate is 98.0% in the observation group of the traditional Chinese medicine provided by the invention, which are both significantly higher than the cure rate (62.5%) and the total effective rate (81.3%) in the control group, with significant difference (P<0.05), the vaginal bleeding period is short, and proportion of the complete curettage of uterine cavity is low.

The invention discloses a built-in obstetric vaginal bleeding negative pressure drainage metering device, which comprises a blood collector for receiving vaginal bleeding and a negative pressure drainage bag connected to the blood collector through a double-lumen tube; the device of the blood collector The wall is a double-layer hollow wall, and a sealed cavity is formed between the inner wall and the outer wall of the blood collector. The material of the blood collector is a flexible material; The drainage part of the drainage bag and the guide part for introducing sterile saline into the cavity; the built-in obstetric vaginal bleeding negative pressure drainage metering device can timely drain and collect vaginal bleeding during cesarean section and postpartum, and measure it accurately in real time The amount of bleeding can assist doctors to quickly and accurately judge the amount of intrapartum and postpartum hemorrhage, which is conducive to early detection and timely rescue of postpartum hemorrhage.

The invention relates to a building method of a preoperative autologus blood donation system for late trimester of pregnancy. A 300ml sealing triple bag system is adopted, the content of anticoagulants in a blood bag is increased, autologus blood of 200 ml is collected, and the anticoagulants and the blood are mixed evenly after the blood is collected and then are stored in a blood storage refrigerator of 4+ / -2.0 DEG C; the blood storage time is 15-35 days before the surgery is performed; objects with autologus blood collected are puerperae with the autologus blood donation indications, and the autologus blood donation indications are puerperae who do not have presentations of parturition signs, vaginal bleeding, growth restriction of fetuses or intrauterine hypoxia and are stable in state of illness after diseases of a cardiovascular system, diabetes, hypertensive disorder complicating pregnancy, infectious diseases and medical complications are excluded. The scientific evidence is provided for standard building of a preoperative autologus blood donation technology for late trimester of pregnancy, and therefore preoperative autologus blood donation is better applied to patients of obstetrics, the system is safer, more effective and more economical, and application and popularization of the preoperative autologus blood donation in the obstetrics are better promoted.

Methods for treating FSH related conditions, such as prostatic intraepithelial neoplasia, pedophilia, infertility, or vaginal bleeding, with GnRH antagonists are disclosed. The methods of the invention generally feature administering to a subject a GnRH antagonist suitable for in vivo administration and able to reduce both plasma FSH and LH levels in a subject, in an amount or in a formulation effective to reduce plasma FSH levels in the subject to a symptom alleviating level. In vitro fertilization and male contraceptive methods are also provided.

Methods for treating FSH related conditions, such as prostatic intraepithelial neoplasia, pedophilia, infertility, or vaginal bleeding, with GnRH antagonists are disclosed. The methods of the invention generally feature administering to a subject a GnRH antagonist suitable for in vivo administration and able to reduce both plasma FSH and LH levels in a subject, in an amount or in a formulation effective to reduce plasma FSH levels in the subject to a symptom alleviating level. In vitro fertilization and male contraceptive methods are also provided.

The invention discloses a pharmaceutical composition for treating precocious puberty and a preparation method thereof. The pharmaceutical composition for treating precocious puberty in infants comprises the following raw materials: raw rehmannia, Alisma, Digupi, Moutan cortex, Gentiana, Prunella vulgaris, malt, turtle shell, chrysanthemum, kelp, scrophulariaceae, Gallus gallis, and oyster. The preparation method of the pharmaceutical composition comprises the following steps: S1, decocting malt for 2 to 5 times, combining the decoctions and filtering, adding an equal amount of ethanol to the filtrate, stirring the mixture and standing overnight, taking the supernatant and recovering the ethanol until free Alcoholic taste, set aside; S2, grind turtle shells and oysters into powder, put them into a cloth bag, add water to decoct with other medicinal materials for 2-5 times, combine the decoction and filter, obtain the filtrate and let it stand overnight; S3, take S2 The supernatant of the filtrate is added to the supernatant of S1 and filtered, and the pharmaceutical composition is obtained through post-processing. The invention has the effects of clearing liver and dispelling stagnation, nourishing yin and purging fire, can treat young girls' breast distension and pain and vaginal bleeding, and has the effect of treating children's precocious puberty.

The invention provides medicine composition for treating colporrhagia in woman climacterium. The medicine composition comprises a first active component, namely, components of a Kuntai capsule and a second active component, namely, mifepristone, wherein the Kuntai capsule comprises cooked rehmannia roots, rhizoma coptidis, radix paeoniae alba, radix scutellariae, ass-hide glue and poria cocos. Through combined application of the Kuntai capsule and the mifepristone of the composition, the composition is obvious superior to a singleprescription of the same dosage in effect of treating the colporrhagia in the woman climacterium, the fact indicates that the two medicines have synergistic effects when being combined for usage, and meanwhile, the composition is free of obvious toxicity and side effects and more significant in treatment effect.

The invention relates to a preparation method for a medicament for treating colporrhagia caused by medical abortion. The method comprises the following steps: adding 22,000ml of water into 9 grams of rubus setchuenensis bur, 6 grams of scutellaria indica, 5 grams of lindera communis, 8 grams of alpinia zerumbet, 6 grams of meliosma rigida, 8 grams of korean raspberry root, 7 grams of japanese pachysandra herb, 3 grams of asparagus fern, 2 grams of pogostemon auricularius, 3 grams of pilea cavaleriei, 6 grams of cold white grass, 7 grams of microcos paniculata, 3 grams of spreading violet, 6 grams of filipendula palmate, 5 grams of campylotropis macrocarpa, 3 grams of great willowherb herb, 6 grams of equisetum silvaticum and 2 grams of dicliptera chinensis, putting the materials into a flask with a condenser, heating the flask under 80 DEG C for 6 hours, filtrating, and collecting filtrate. The medicament for treating the colporrhagia caused by the medical abortion, prepared by the method disclosed by the invention, has a reasonable formula and a definite effect and can effectively treat the colporrhagia caused by the medical abortion.

The invention relates to a medicine for treating vaginal bleeding after medical abortion. The medicine is prepared from the following medicinal raw materials in parts by weight: 80 parts of scorzonera albicaulis bunge, 70 parts of pink reineckea herb, 60 parts of helicteres isora, 55 parts of schisandra lancifolia, 50 parts of pampanin shuteria herb, 55 parts of sida acuta, 45 parts of primula efarinosa pax, 35 parts of cissus hexangularis and 30 parts of licorice root. The medicine is reasonable in formula and exact in curative effect, and can be used for effectively treating vaginal bleeding after medical abortion.

The invention relates to a medicine for treating climacteric syndrome, especially women's senile and atrophic vaginitis and a preparation method thereof. The medicine provided by the invention contains prasterone sulfate sodium. The drug overcomes the defects of the existing drugs, has a good curative effect on the treatment of menopausal syndrome, especially women's senile and atrophic vaginitis, has little toxic and side effects, has no stimulation to the endometrium, and does not cause vaginal bleeding. There is no risk of cancer caused by ordinary hormone therapy.

The invention discloses a traditional Chinese medicine composition for treating scarred uterine pregnancy. 10 parts of flowers, 10 parts of rehmannia glutinosa, 6 parts of Chuanxiong, 10 parts of angelica, 10 parts of red peony, 10 parts of Chuan Achyranthes, 10 parts of trichosanthes, and 3 parts of licorice. The invention mainly focuses on eliminating symptoms and killing embryos, softening hard masses and resolving stagnation, supplemented by selecting a variety of components with functions of promoting blood circulation and removing blood stasis. When the present invention is combined with UAE+ curettage for the treatment of CSP, it can more thoroughly remove the residual gestational sac, shorten the vaginal bleeding time, further improve the treatment effect and reduce the occurrence of complications.

The invention discloses a built-in negative pressure drainage metering device for obstetric vaginal bleeding, and belongs to the field of medical instruments. The device comprises a main body, whereina rotating shaft is fixedly installed at the middle section of the main body; a cleaning frame A and a cleaning frame B are fixedly installed in the left and right sides of the main body; a catheterA and a catheter B are detachably connected to the outer sides of the cleaning frame A and the cleaning frame B respectively; a flow guide pipe is detachably installed in a negative pressure catheter;a blood box is detachably connected to the other end of the flow guide pipe; and a grip strength air bag is connected to the outer side of the negative pressure catheter in an embedded mode. Accordingly, by installing the main body, the rotating shaft, a contraction cavity, a sliding device, a spring, a contraction roller, a contraction rope, the cleaning frame A, the cleaning frame B, the catheter A, the catheter B, a collecting cavity, a blocking curtain, the negative pressure catheter, the grip strength air bag and the blood box, the device can be suitable for pregnant women of different constitutions to use, meanwhile, bleeding in the bodies of the pregnant women can be discharged rapidly, the bleeding amount can be measured rapidly, and the using effect is improved.

The invention discloses a medicine for stopping bleeding and relieving fester in gynecological department. The medicine is prepared from the following raw materials in parts by weight: 0.1-4 parts of borneol, 0.3-5 parts of minium, 0.2-10 parts of indigo naturalis, 1-15 parts of talcum powder, 0.3-15 parts of alum, 2-17 parts of fructus forsythiae and 1-15 parts of radix arnebiae seu lithospermi. A preparation method comprises preparation of pills and preparation of a water aqua. The medicine provided by the invention has functions of killing bacteria and resisting insects, clearing away heat and toxic materials, removing slough and promoting growth of tissue regeneration, alleviating pain and relieving itching, removing foreign smell, stopping bleeding and stimulating menstrual flow. The medicine has a good effect on vaginal bleeding and fester; and in addition, the medicine can also take health care effects of moistening and tightening vaginae.

The invention relates to a traditional Chinese medicine combination for treating gynaecological hemorrhagic disease, belongs to the traditional Chinese medicine field. The invention is characterized in that the traditional Chinese medicine combination is made from raw ingredients by weight parts as follows: Prepared Nutgrass Galingale Rhizome is 8 to 25 parts, typha orientalis stir-fried with vinegar is 5 to 20 parts, Myrrha Preparata is 8 to 20 parts, panpax notoginseng is 3 to 15 parts, stir-frying bitter orange is 8 to 20 parts, leonurus japonicus is 8 to 25 parts, and agrimony is 8 to 25 parts. The invention has the efficacies of thoroughfare regulating as well as hemostasia, and blood stasis and detoxication dissolving. The traditional Chinese medicine combination is mainly used for dysfunctional uterine bleeding, blood menostaxis, excess menstrual blood, postpartum lochiorrhea, the uterine bleeding caused by curettage, intrauterine device and induced labor, hysteromyoma, and vaginal bleeding caused by cervical erosion. The traditional Chinese medicine combination can achieve hemostasia purpose on various syndromes of deficiency complicated with excess.

The present document is directed to a pharmaceutical composition comprising at least one non-ionic cellulose ether, wherein said composition has a viscosity of 35000 cP or more, an osmolality of from about 10 to about 300 mOsmol / kg, and a pH of from about 3 to about 4. The composition may be used in the treatment and / or prevention of a climacteric disorder, wherein said climacteric disorder is a selected from the group consisting of vaginal dryness, vaginal irritation, vaginal itching, dysuria, dyspareunia, and / or vaginal bleeding during and / or after sexual intercourse and any combination thereof.